Metabolon is a leading provider of metabolomics research and development capabilities, providing many of the most well-known pharma, academic, and consumer institutions with critical and actionable information on the small molecules involved in metabolism that they cannot obtain from any other company today.
Metabolon is a leader in the metabolomics field, namely the systematic measurement and biological interpretation of the low molecular weight (~50-1500 Da) metabolites within a biological sample. Metabolon is a commercial-stage metabolomics company pioneering biomarker discovery and the development of innovative, cost-effective diagnostic tests.
Metabolon was founded in 2000 and maintains a 40,000 square foot headquarters and CLIA-certified, CAP-accredited lab in Research Triangle Park, North Carolina. The privately-held company employs ~150 people globally, with experts in the fields of biochemistry, mass spectrometry, and software development, and has conducted more than 4,000 studies across various therapeutic areas, 500+ of which have resulted in publications in leading journals such as Nature, Cell, Science, and JCI.